Evidence map›Paper›PMID 39639093›Full record

ArticleScientific reports2024

Immunomodulatory properties of polysaccharide extract samples from Cyanobacterium sp. Rippka B-1200.

Stanislav Sukhikh, Vladimir Popov, Egor Kashinskikh, Ekaterina Budenkova, Svetlana Ivanova, Olga Babich

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stanislav SukhikhSec "Applied Biotechnologies", Immanuel Kant Baltic Federal University, Kaliningrad, Russia, 236040.
Vladimir PopovFaculty of Medicine, Lomonosov Moscow State University, Moscow, Russia, 119991.
Egor KashinskikhSec "Applied Biotechnologies", Immanuel Kant Baltic Federal University, Kaliningrad, Russia, 236040.
Ekaterina BudenkovaSec "Applied Biotechnologies", Immanuel Kant Baltic Federal University, Kaliningrad, Russia, 236040.
Svetlana IvanovaInstitute of NBICS-Technologies, Kemerovo State University, Krasnaya Street 6, Kemerovo, Russia, 650043. pavvm2000@mail.ru.
Olga BabichSec "Applied Biotechnologies", Immanuel Kant Baltic Federal University, Kaliningrad, Russia, 236040.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyanobacteria are most abundant in aquatic systems and can grow in freshwater, saline or brackish water, and cold/hot springs. Cyanobacteria have attracted considerable research attention in the last decade as a potential source of numerous biological products in large quantities, such as biofuels, pigments, polyunsaturated fatty acids, nutraceuticals, enzymes, and polysaccharides. Unlike most plant and fungal polysaccharides, the chemical composition, immunomodulatory activity, and molecular mechanisms of action of Cyanobacterium sp. Rippka B-1200 polysaccharides have been studied much less. The complexity of their primary structure due to the high variability of monosaccharides, their diverse bonds, the presence of substituents and high viscosity made detailed structural studies of cyanobacterial polysaccharides rare, which determines the need for analysis of cyanobacteria biomass components to identify active metabolites with promising biological activity. The aim of this study was to investigate the immunomodulatory properties of polysaccharides from Cyanobacterium sp. Rippka B-1200. Pharmacological and nutraceutical value of Cyanobacterium sp. Rippka B-1200 has been set, defining our study's scientific novelty. As a result, the molecular weight of immunoactive polysaccharide (6.0-8.0 kDa) was determined. The analysis shows that endopolysaccharide samples at a concentration of 300 mg/kg showed no significant immunomodulatory effect (1.60 ± 0.15 mg/g), and the thymus mass index of animals in the experimental group was comparable to that of the control group in which animals were immunosuppressed with cyclophosphamide (1.15 ± 0.24 mg/g). When exopolysaccharide samples were used at a concentration of 600 mg/kg, the thymus mass index of animals in the experimental group (3.60 ± 0.32 mg/g) was statistically comparable to that of the control group (without polysaccharide) in which immunosuppression was not induced (thymus index was 3.70 ± 0.25 mg/g). It was found that endopolysaccharide samples at a concentration of 600 mg/kg also exhibited high immunomodulatory activity. When Cyanobacterium sp. Rippka B-1200 endopolysaccharide samples were used, no internal organ changes were observed in experimental animals after immunosuppression. The empirical results presented in the study may find application in the development of both pharmaceutical and cosmetic products.

Indexed as

CyanobacteriaAnimalsImmunologic FactorsImmunomodulating AgentsMaleMicePolysaccharidesPolysaccharides, BacterialRatsImmunologic FactorsImmunomodulating AgentsPolysaccharidesPolysaccharides, BacterialCyanobacterium sp.EndopolysaccharidesExopolysaccharidesImmunomodulatory properties of polysaccharidesIn vivo experiment

Identifiers

PMID39639093
PMCPMC11621559

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.